The Advisory Board Company Reports Results For Quarter Ended December 31, 2013

Company Reports Quarterly Revenue of $131 Million and Contract Value Growth of 16%; Issues Guidance for Calendar Year 2014; and Announces Launch of New Programs

06 Feb, 2014, 16:45 ET from The Advisory Board Company

WASHINGTON, Feb. 6, 2014 /PRNewswire/ -- The Advisory Board Company (NASDAQ: ABCO) today announced financial results for the quarter ended December 31, 2013, which is the third quarter of its 2014 fiscal year.  Revenue for the quarter increased 13% to $131.0 million, from $116.2 million for the quarter ended December 31, 2012.  Contract value increased 16% to $522.5 million as of December 31, 2013, up from $450.0 million as of December 31, 2012.  For the quarter ended December 31, 2013, net income attributable to common stockholders was $3.8 million, or $0.10 per diluted share, compared to net income attributable to common stockholders of $4.6 million, or $0.13 per diluted share, for the quarter ended December 31, 2012.  For the quarter ended December 31, 2013, adjusted EBITDA was $21.4 million, up from $19.7 million for the quarter ended December 31, 2012.  Adjusted net income for the quarter ended December 31, 2013 was $9.5 million, or $0.26 per diluted share, compared to $10.3 million, or $0.28 per diluted share, for the quarter ended December 31, 2012.  Adjusted EBITDA, adjusted net income, and non-GAAP earnings per diluted share are all non-GAAP financial measures.

(Logo: http://photos.prnewswire.com/prnh/20110802/PH45999LOGO)

For the nine months ended December 31, 2013, revenue increased 16% to $382.6 million, from $331.1 million for the nine months ended December 31, 2012. Net income attributable to common stockholders was $16.5 million, or $0.45 per diluted share, for the nine months ended December 31, 2013, compared to net income attributable to common stockholders of $16.9 million, or $0.47 per diluted share, for the same period in the prior fiscal year.  For the nine months ended December 31, 2013, adjusted EBITDA was $66.2 million, up from $61.3 million for the nine months ended December 31, 2012.  Adjusted net income for the nine months ended December 31, 2013 was $32.3 million, or $0.88 per diluted share, compared to $33.1 million, or $0.91 per diluted share, for the nine months ended December 31, 2012. 

Robert Musslewhite, Chairman and Chief Executive Officer of The Advisory Board Company, commented, "I am pleased that 2013 was another year of strong performance for The Advisory Board Company. We again not only achieved a mid-teens growth rate but also reinvested in the business while delivering solid bottom-line growth, and we extended our track record of taking advantage of our market-leading position in our industries to drive exceptional impact for our members. With a compound annual growth rate of 18% for contract value over the last five years, our consistent performance illustrates the power of our formula: driving tangible value to our members, earning their trust and the right to work with them in deeper and more comprehensive ways, which spurs incremental growth. Given our scalable model, this incremental growth is highly profitable, allowing us to reinvest in developing new ways to serve member needs and seed future growth while also delivering strong results for our shareholders."

Mr. Musslewhite continued, "I am pleased to announce today two examples of that investment: First, the launch of our Payment Integrity Forecaster Program. This renewable health care software-based program provides a SaaS solution that enables members to understand and to project financial scenarios under value-based care dynamics. Built on the Concuity platform and incorporating proprietary intellectual property on contracting techniques, the Payment Integrity Forecaster Program features a uniquely flexible contracting solution able to integrate data across multiple care settings. The software enables providers not only to understand the economics of a value-based initiative but also, importantly, to proactively design contracts around the anticipated areas of clinical quality improvement. In a time of tremendous flux, the Payment Integrity Forecaster Program provides our members the tools to do more than just survive a difficult transition, and to instead be agents of change and be fairly paid for making smart changes to drive better care quality."

Mr. Musslewhite concluded, "I am also pleased to announce today our latest higher education launch, our Advancement Forum, a renewable research program for university advancement officers that provides best practice research, peer networking, and benchmarking tools to help address the key issues facing university fundraisers today. With higher education fundraising totaling over $30 billion across the country last year, colleges and universities are turning to the fundraising function with increasing urgency to help alleviate the pressure on university revenues caused by declining state appropriations, budget shortfalls, and cuts to federal research funding. The Advancement Forum both leverages insights from our long-standing and well-regarded Health Care Philanthropy program and conducts original research focused on such university-specific topics as driving ROI from alumni relations and engaging with the broader academy. With the Advancement Forum, we are excited to expand our research footprint serving higher education, as this has consistently proven to be a platform for future growth and new ways to help solve our members' most pressing problems."

Outlook for Calendar Year 2014 

The Company is providing financial guidance for calendar year 2014.  For the calendar year, the Company expects revenue to be in a range of approximately $570 million to $580 million, adjusted EBITDA to be in a range of approximately $101 million to $106 million, and non-GAAP earnings per diluted share to be in a range of approximately $1.18 to $1.30.  For calendar year 2014, the Company expects stock-based compensation expense to be approximately $22 million, and expects amortization from acquisition-related intangible assets to be approximately $11 million.  For calendar year 2014, the Company expects an effective tax rate in a range of approximately 38.5% to 39.5%. 

Non-GAAP Financial Measures 

This press release and the accompanying tables present information about the Company's adjusted EBITDA, adjusted net income, and non-GAAP earnings per diluted share, which are non-GAAP financial measures provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America ("GAAP").  The term "adjusted EBITDA" for the three and nine months ended December 31, 2013 and 2012 refers to net income attributable to common stockholders before adjustment for the items set forth in the first table.  The term "adjusted net income" for the three and nine months ended December 31, 2013 and 2012 refers to net income attributable to common stockholders excluding the net of tax effect of the items set forth in the second table below.  The term "non-GAAP earnings per diluted share" for the three and nine months ended December 31, 2013 and 2012 refers to earnings per diluted share excluding the net of tax effect of the items set forth in the third table below. 

A reconciliation of the foregoing historical non-GAAP financial measures to the most directly comparable historical GAAP financial measures is provided below for each of the periods indicated.  It is not practicable to provide a reconciliation of forecasted adjusted EBITDA or non-GAAP earnings per diluted share to the most directly comparable GAAP financial measures because certain items required for the forecast of such GAAP financial measures, including fair value adjustments to acquisition-related earn-out liabilities, equity in loss of unconsolidated entity, and gains and losses on investment in common stock warrants, cannot reasonably be estimated or predicted at this time.

 

 

 

Three Months Ended

Nine Months Ended

December 31,

December 31,

2013

2012

2013

2012

Net income attributable to common

 stockholders

$    3,771

$    4,592

$    16,465

$   16,866

Equity in loss of unconsolidated entities

1,413

1,870

3,320

4,586

Provision for income taxes

3,170

4,012

12,311

13,250

Other income, net

(360)

(738)

(1,974)

(2,002)

Depreciation and amortization

8,712

5,338

21,952

14,029

Acquisition and similar transaction charges

252

573

851

Fair value adjustments to acquisition-related

   earn-out liabilities

859

(250)

3,359

Stock-based compensation expense

4,728

3,471

13,794

10,382

     Adjusted EBITDA

$    21,434

$    19,656

$    66,191

$    61,321

Three Months Ended

Nine Months Ended

December 31,

December 31,

2013

2012

2013

2012

Net income attributable to common

 stockholders

$    3,771

$    4,592

$    16,465

$   16,866

Equity in loss of unconsolidated entities

1,413

1,870

3,320

4,586

Amortization of acquisition-related intangibles,

   net of tax

1,424

1,030

3,790

2,611

Acquisition and similar transaction charges, net

   of tax

155

352

525

Fair value adjustments to acquisition-related

   earn-out liabilities, net of tax

530

(154)

2,073

Loss on investment in common stock warrants,

   net of tax

68

Stock-based compensation expense, net of tax

2,908

2,142

8,484

6,406

Adjusted net income

$    9,516

$    10,319

$   32,257

$    33,135

Three Months Ended

Nine Months Ended

December 31,

December 31,

2013

2012

2013

2012

GAAP earnings per diluted share

$    0.10

$   0.13

$    0.45

$    0.47

Equity in loss of unconsolidated entities

0.04

0.05

0.09

0.13

Amortization of acquisition-related intangibles,

   net of tax

0.04

0.03

0.10

0.07

Acquisition and similar transaction charges, net

   of tax

0.01

0.01

Fair value adjustments to acquisition-related

   earn-out liabilities, net of tax

0.01

0.06

Loss on investment in common stock warrants,

   net of tax

Stock-based compensation expense, net of tax

0.08

0.06

0.23

0.18

Non-GAAP earnings per diluted share

$    0.26

$    0.28

$    0.88

$    0.91

 

 

Web and Conference Call Information

As previously announced, the Company will hold a conference call to discuss its third quarter performance this evening, February 6, 2014, at 5:30 p.m. Eastern Time.  The conference call will be available via live webcast on the Company's website at www.advisory.com/IR.  To participate by telephone, the dial-in number is 888.317.6016.  Participants are advised to dial in at least five minutes prior to the call to register.  The webcast will be archived for seven days from 8:00 p.m. Eastern Time on Thursday, February 6, until 11:00 p.m. Eastern Time on Thursday, February 13, 2014.

About The Advisory Board Company

The Advisory Board Company is a global research, technology, and consulting firm partnering with 165,000 leaders in 4,100 organizations across health care and higher education.  Through its innovative membership model, the Company collaborates with executives and their teams to elevate performance and solve their most pressing challenges.  The Company provides strategic guidance, actionable insights, web-based software solutions, and comprehensive implementation and management services.  For more information, visit the firm's website, www.advisory.com.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These statements, including the Company's expectations regarding its revenue, adjusted EBITDA, non-GAAP earnings per diluted share, stock-based compensation expense, amortization of acquisition-related intangibles, and effective tax rate for calendar year 2014 are based on information available to the Company as of February 6, 2014, the date of this news release, as well as the Company's current projections, forecasts, and assumptions, and are subject to risks and uncertainties.  You are hereby cautioned that these statements may be affected by certain factors, including those set forth below.  Consequently, actual operations and results may differ materially from the results discussed or implied in the forward-looking statements, and reported results should not be considered as an indication of future performance.  Factors that could cause actual results to differ materially from those indicated or implied by the forward-looking statements include, among others, changes in the financial condition of the health care industry, our dependence on renewal of membership-based services, the need to attract new business and retain current members and qualified personnel, new product development, competition, risks associated with the Company's software tools and management and advisory services, risks relating to privacy, information security, and other health care-related laws and standards, maintaining our third-party provider relationships and strategic alliances, our ability to license technology from third parties, impairment of goodwill, and various factors related to income and other taxes, as well as other risks and uncertainties described in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2013, which is available for review on the Company's website at www.advisory.com/IR and at the Securities and Exchange Commission's website at www.sec.gov.  Additional information will also be set forth in the Company's Report on Form 10-Q for the quarter ended December 31, 2013, which will be filed with the Securities and Exchange Commission in February 2014. 

Accordingly, readers are cautioned not to place undue reliance on the forward-looking statements made in this news release, which speak only as of the date of this news release. The Company does not undertake to update any of its forward-looking statements, whether as a result of circumstances or events that arise after the date they are made, new information, or otherwise.

 

 

 THE ADVISORY BOARD COMPANY 

 UNAUDITED CONSOLIDATED STATEMENTS OF INCOME 

 AND OTHER OPERATING STATISTICS 

 (In thousands, except per share data) 

 Three Months Ended 

 Selected 

 Nine Months Ended 

 Selected 

 December 31, 

 Growth 

 December 31, 

 Growth 

2013

2012

 Rates 

2013

2012

 Rates 

 Statements of Income 

 Revenue 

$    131,038

$    116,231

12.7%

$    382,595

$     331,131

15.5%

 Cost of services, excluding depreciation and

amortization (1) (2) (6) (7) 

69,521

62,764

205,328

176,401

 Member relations and marketing (1) 

25,500

21,826

69,886

62,431

 General and administrative (1) (3) 

19,430

16,567

55,426

45,678

 Depreciation and amortization (4) (6) 

8,712

5,338

21,952

14,029

      Operating income (5) 

7,875

9,736

30,003

32,592

 Other income, net 

360

738

1,974

2,002

      Income before provision for income taxes 

        and equity in loss of unconsolidated entities 

8,235

10,474

31,977

34,594

 Provision for income taxes 

(3,170)

(4,012)

(12,311)

(13,250)

 Equity in loss of unconsolidated entities 

(1,413)

(1,870)

(3,320)

(4,586)

      Net income before allocation to noncontrolling interest 

3,652

4,592

16,346

16,758

 Net loss attributable to noncontrolling interest 

119

-

119

108

      Net income attributable to common

         stockholders (6) (7) 

$        3,771

$        4,592

$      16,465

$       16,866

 Net income attributable to common

   stockholders per share 

 Basic 

$          0.10

$          0.13

$          0.46

$           0.49

 Diluted 

$          0.10

$          0.13

$          0.45

$           0.47

 Weighted average common shares outstanding 

 Basic 

36,063

34,949

35,812

34,597

 Diluted 

37,112

36,385

36,876

36,231

 Contract Value (at end of period)  

$    522,532

$    450,027

16.1%

 Percentages of Revenue 

 Cost of services, excluding depreciation and

     amortization (1) (2) 

53.1%

54.0%

53.7%

53.3%

 Member relations and marketing (1) 

19.5%

18.8%

18.3%

18.9%

 General and administrative (1) (3) 

14.8%

14.3%

14.5%

13.8%

 Depreciation and amortization (4) 

6.6%

4.6%

5.7%

4.2%

 Operating income 

6.0%

8.4%

7.8%

9.8%

 Net income attributable to common stockholders 

2.9%

4.0%

4.3%

5.1%

(1)

 Amounts include stock-based compensation, as follows: 

 Cost of services 

1,456

1,009

4,145

3,002

 Member relations and marketing 

944

656

2,845

1,992

 General and administrative 

2,328

1,806

6,804

5,388

(2)

 Amounts include fair value adjustments of acquisition-related earn-out liabilities, as follows: 

 Cost of services 

-

859

(250)

3,359

(3)

 Amounts include acquisition and transaction related costs, as follows: 

 General and administrative 

-

252

573

851

(4)

 Amounts include amortization of acquisition-related intangibles, as follows: 

 Depreciation and amortization 

2,315

1,669

6,163

4,231

(5)

 Amounts include loss on investment in common stock warrants, as follows: 

 Other income, net 

-

-

-

(110)

(6)

 Prior period amounts have been revised to correct an immaterial error in the calculation of capitalized developed software, as follows: 

 Cost of services 

-

(359)

-

(1,077)

 Depreciation and amortization 

-

115

-

290

 Net income attributable to common

      stockholders 

-

150

-

483

(7)

 Prior periods amounts have been revised to correct an immaterial error in the timing of an acquisition-related earn-out fair value adjustment, as follows: 

 Cost of services 

-

-

-

(1,000)

 Net income attributable to common

     stockholders 

-

-

-

619

 

 

THE ADVISORY BOARD COMPANY

 CONSOLIDATED BALANCE SHEETS

 (In thousands)

December 31,

March 31,

2013

2013

 (unaudited)

 ASSETS

 Current assets:

 Cash and cash equivalents

$               52,717

$               57,829

 Marketable securities, current

1,044

16,611

 Membership fees receivable, net

464,517

370,321

 Prepaid expenses and other current assets

15,796

15,477

 Deferred income taxes, current

9,980

7,664

 Total current assets

544,054

467,902

 Property and equipment, net

100,311

73,572

 Intangible assets, net

34,654

32,381

 Deferred incentive compensation and other charges

85,050

73,502

 Deferred income taxes, net of current portion

3,859

2,993

 Marketable securities, net of current portion

137,698

140,228

 Goodwill

129,424

95,540

 Investments in and advances to unconsolidated entities

17,742

6,265

 Other non-current assets

5,550

5,550

 Total assets

$          1,058,342

$             897,933

 LIABILITIES AND STOCKHOLDERS' EQUITY

 Current liabilities:

 Deferred revenue, current

$             451,993

$             398,541

 Accounts payable and accrued liabilities

77,459

75,089

 Accrued incentive compensation

25,283

21,033

 Total current liabilities

554,735

494,663

 Deferred revenue, net of current portion

165,090

104,484

 Other long-term liabilities

16,721

15,866

 Total liabilities

736,546

615,013

 Redeemable noncontrolling interest

100

100

 The Advisory Board Company's stockholders' equity:

 Common stock

361

351

 Additional paid-in capital

418,055

375,622

 Accumulated deficit

(93,997)

(94,306)

 Accumulated other comprehensive (loss) income

(2,496)

1,261

 Total stockholders' equity controlling interest

321,923

282,928

 Equity attributable to noncontrolling interest

(227)

(108)

 Total stockholders' equity

321,696

282,820

 Total liabilities and stockholders' equity

$          1,058,342

$             897,933

 

 

THE ADVISORY BOARD COMPANY

 UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS

 (In thousands)

 Nine Months Ended December 31,

2013

2012

 Cash flows from operating activities:

 Net income before allocation to noncontrolling interest

$        16,346

$        16,758

 Adjustments to reconcile net income before allocation to 

 noncontrolling interest to net cash provided by operating activities:

 Depreciation and amortization

21,952

14,029

 Deferred income taxes

(585)

(649)

 Excess tax benefits from stock-based awards

(16,583)

(11,755)

 Stock-based compensation expense

13,794

10,382

 Amortization of marketable securities premiums

2,020

1,473

 Loss on investment in common stock warrants

-

110

 Equity in loss of unconsolidated entities

3,320

4,586

 Changes in operating assets and liabilities:

 Membership fees receivable

(79,697)

(84,582)

 Prepaid expenses and other current assets

16,264

(1,772)

 Deferred incentive compensation and other charges

(11,548)

(9,894)

 Deferred revenue

101,861

115,486

 Accounts payable and accrued liabilities

3,921

26,543

 Acquisition-related earn-out payments

(2,212)

(3,011)

 Accrued incentive compensation

3,877

(45)

 Other long-term liabilities

855

(3,437)

 Net cash flows provided by operating activities

73,585

74,222

 Cash flows from investing activities:

 Purchases of property and equipment

(35,692)

(26,457)

 Capitalized external use software development costs

(3,722)

(2,555)

 Investments in and loans to unconsolidated entities

(15,641)

-

 Cash paid for acquisition, net cash acquired

(46,036)

(31,887)

 Redemptions of marketable securities

48,676

35,220

 Purchases of marketable securities

(38,762)

(42,889)

 Net cash flows used in investing activities

(91,177)

(68,568)

 Cash flows from financing activities:

 Proceeds from issuance of stock from exercise of stock options

17,478

21,580

 Withholding of shares to satisfy minimum employee tax withholding

(5,796)

(3,844)

 Proceeds from issuance of stock under employee stock purchase plan

374

255

 Excess tax benefits from stock-based awards

16,583

11,755

 Contributions from noncontrolling interest

-

100

 Acquisition-related earn-out payments

-

(1,400)

 Purchases of treasury stock

(16,159)

(12,999)

 Net cash flows provided by financing activities

12,480

15,447

 Net increase in cash and cash equivalents

(5,112)

21,101

 Cash and cash equivalents, beginning of period

57,829

60,642

 Cash and cash equivalents, end of period

$        52,717

$        81,743

 

 

 

SOURCE The Advisory Board Company



RELATED LINKS

http://www.advisoryboardcompany.com